These results indicate that a single treatment with PFPE-CH at a dose of 200 mg/kg BW can reduce breast tumor volume and tumor histology by decreasing IL-4 and IL-6 levels and is more effective when combined with doxorubicin. The gene discussed is IL4; the disease is breast neoplasm.